The effect of ultrasound-guided rectus sheath block on postoperative analgesia in robot assisted prostatectomy: A randomized controlled trial.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
26 Apr 2024
26 Apr 2024
Historique:
medline:
26
4
2024
pubmed:
26
4
2024
entrez:
26
4
2024
Statut:
ppublish
Résumé
Postoperative pain continues to represent an important problem even after minimally invasive robotic-assisted laparoscopic radical prostatectomy, which results in discomfort in the postoperative period and sometimes prolongs hospital stays. Regional anesthesia and analgesia techniques are used in addition to systemic analgesics with the multimodal approach in postoperative pain management. Ultrasound-guided fascial plane blocks are becoming increasingly important, especially in minimally invasive surgeries. Another important cause of discomfort is urinary catheter pain. The present randomized controlled study investigated the effect of rectus sheath block on postoperative pain and catheter-related bladder discomfort in robotic prostatectomy operations. This randomized controlled trial was conducted from March to August 2022. Written informed consent was obtained from all participants. Approval for the study was granted by the Clinical Research Ethics Committee. All individuals provided written informed consent, and adults with American Society of Anesthesiologists Physical Condition classification I to III planned for robotic prostatectomy operations under general anesthesia were enrolled. Following computer-assisted randomization, patients were divided into 2 groups, and general anesthesia was induced in all cases. Rectus sheath block was performed under general anesthesia and at the end of the surgery. No fascial plane block was applied to the patients in the non-rectus sheath block (RSB) group.Postoperative pain and urinary catheter pain were assessed using a numerical rating scale. Fentanyl was planned as rescue analgesia in the recovery room. In case of numerical rating scale scores of 4 or more, patients were given 50 µg fentanyl IV, repeated if necessary. The total fentanyl dose administered was recorded in the recovery room. IV morphine patient-controlled analgesia was planned for all patients. All patients' pain (postoperative pain at surgical site and urethral catheter discomfort) scores and total morphine consumption in the recovery unit and during follow-ups on the ward (3, 6, 12, and 24 hours) in the postoperative period were recorded. Sixty-one patients were evaluated. Total tramadol consumption during follow-up on the ward was significantly higher in the non-RSB group. Fentanyl consumption in the postanesthesia care unit was significantly higher in the non-RSB group. Total morphine consumption was significantly lower in the RSB group at 0 to 12 hours and 12 to 24 hours. Total opioid consumption was 8.81 mg in the RSB group and 19.87 mg in the non-RSB group. A statistically significant decrease in urethral catheter pain was noted in the RSB group at all time points. RSB exhibits effective analgesia by significantly reducing postoperative opioid consumption in robotic prostatectomy operations.
Sections du résumé
BACKGROUND
BACKGROUND
Postoperative pain continues to represent an important problem even after minimally invasive robotic-assisted laparoscopic radical prostatectomy, which results in discomfort in the postoperative period and sometimes prolongs hospital stays. Regional anesthesia and analgesia techniques are used in addition to systemic analgesics with the multimodal approach in postoperative pain management. Ultrasound-guided fascial plane blocks are becoming increasingly important, especially in minimally invasive surgeries. Another important cause of discomfort is urinary catheter pain. The present randomized controlled study investigated the effect of rectus sheath block on postoperative pain and catheter-related bladder discomfort in robotic prostatectomy operations.
METHODS
METHODS
This randomized controlled trial was conducted from March to August 2022. Written informed consent was obtained from all participants. Approval for the study was granted by the Clinical Research Ethics Committee. All individuals provided written informed consent, and adults with American Society of Anesthesiologists Physical Condition classification I to III planned for robotic prostatectomy operations under general anesthesia were enrolled. Following computer-assisted randomization, patients were divided into 2 groups, and general anesthesia was induced in all cases. Rectus sheath block was performed under general anesthesia and at the end of the surgery. No fascial plane block was applied to the patients in the non-rectus sheath block (RSB) group.Postoperative pain and urinary catheter pain were assessed using a numerical rating scale. Fentanyl was planned as rescue analgesia in the recovery room. In case of numerical rating scale scores of 4 or more, patients were given 50 µg fentanyl IV, repeated if necessary. The total fentanyl dose administered was recorded in the recovery room. IV morphine patient-controlled analgesia was planned for all patients. All patients' pain (postoperative pain at surgical site and urethral catheter discomfort) scores and total morphine consumption in the recovery unit and during follow-ups on the ward (3, 6, 12, and 24 hours) in the postoperative period were recorded.
RESULTS
RESULTS
Sixty-one patients were evaluated. Total tramadol consumption during follow-up on the ward was significantly higher in the non-RSB group. Fentanyl consumption in the postanesthesia care unit was significantly higher in the non-RSB group. Total morphine consumption was significantly lower in the RSB group at 0 to 12 hours and 12 to 24 hours. Total opioid consumption was 8.81 mg in the RSB group and 19.87 mg in the non-RSB group. A statistically significant decrease in urethral catheter pain was noted in the RSB group at all time points.
CONCLUSION
CONCLUSIONS
RSB exhibits effective analgesia by significantly reducing postoperative opioid consumption in robotic prostatectomy operations.
Identifiants
pubmed: 38669407
doi: 10.1097/MD.0000000000037975
pii: 00005792-202404260-00051
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e37975Informations de copyright
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors have no funding and conflicts of interest to disclose.
Références
Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;2013:CD004720.
Davis M, Egan J, Marhamati S, et al. Retzius-sparing robot-assisted robotic prostatectomy: past, present, and future. Urol Clin North Am. 2021;48:11–23.
Howard JM. Robotic, laparoscopic, and open radical prostatectomy-is the jury still out? JAMA Netw Open. 2021;4:e2120693.
Ahlering TE, Woo D, Eichel L, et al. Robot-assisted versus open radical prostatectomy: a comparison of one surgeon’s outcomes. Urology. 2004;63:819–22.
Coughlin GD, Yaxley JW, Chambers SK, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19:1051–60.
Knipper S, Hagedorn M, Sadat-Khonsari M, et al. Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomy. World J Urol. 2020;38:1451–7.
Lemoine A, Witdouck A, Beloeil H, et al. PROSPECT Working Group Of The European Society of Regional Anaesthesia and Pain Therapy (ESRA). PROSPECT guidelines update for evidence-based pain management after prostatectomy for cancer. Anaesth Crit Care Pain Med. 2021;40:100922.
Talwar R, Xia L, Serna J, et al. Preventing excess narcotic prescriptions in new robotic surgery discharges: the PENN prospective cohort quality improvement initiative. J Endourol. 2020;34:48–53.
Bae J, Kim HC, Hong DM. Intrathecal morphine for postoperative pain control following robot-assisted prostatectomy: a prospective randomized trial. J Anesth. 2017;31:565–71.
Martinschek A, Pfalzgraf D, Rafail B, et al. Transurethral versus suprapubic catheter at robot-assisted radical prostatectomy: a prospective randomized trial with 1-year follow-up. World J Urol. 2016;34:407–11.
Batley SE, Prasad V, Vasdev N, et al. Post-operative pain management in patients undergoing robotic urological surgery. Curr Urol. 2016;9:5–11.
Aceto P, Beretta L, Cariello C, et al. Società Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI), Società Italiana di Ginecologia e Ostetricia (SIGO), and Società Italiana di Urologia (SIU). Joint consensus on anesthesia in urologic and gynecologic robotic surgery: specific issues in management from a task force of the SIAARTI, SIGO, and SIU. Minerva Anestesiol. 2019;85:871–85.
Ashrafi AN, Yip W, Graham JN, et al. Implementation of a multimodal opioid-sparing enhanced recovery pathway for robotic-assisted radical prostatectomy. J Robot Surg. 2022;16:715–21.
Congnard D, Vincendeau S, Lahjaouzi A, et al. Outpatient robot-assisted radical prostatectomy: a feasibility study. Urology. 2019;128:16–22.
Theisen KM, Davies BJ. A radical proposition: opioid-sparing prostatectomy. Eur Urol Focus. 2020;6:215–7.
Chin KJ, Versyck B, Elsharkawy H, et al. Anatomical basis of fascial plane blocks. Reg Anesth Pain Med. 2021;46:581–99.
El-Boghdadly K, Wolmarans M, Stengel AD, et al. Standardizing nomenclature in regional anesthesia: an ASRA-ESRA Delphi consensus study of abdominal wall, paraspinal, and chest wall blocks. Reg Anesth Pain Med. 2021;46:571–80.
Chiancone F, Fabiano M, Ferraiuolo M, et al. Clinical implications of transversus abdominis plane block (TAP-block) for robot assisted laparoscopic radical prostatectomy: a single-institute analysis. Urologia. 2021;88:25–9.
Rogers T, Bhat KRS, Moschovas M, et al. Use of transversus abdominis plane block to decrease pain scores and narcotic use following robot-assisted laparoscopic prostatectomy. J Robot Surg. 2021;15:81–6.
Shim JW, Jung S, Moon HW, et al. Rectus sheath block for acute pain management after robot-assisted laparoscopic prostatectomy. Asian J Surg. 2022;45:1843–8.
Stamm A, Ferenczi B, Porter C, et al. Impact of catheter size on pain and continence following robotic prostatectomy. Can J Urol. 2020;27:10363–8.
Veerman H, Houwink API, Schutte PFE, et al. Intraoperative strategies to reduce catheter-related bladder discomfort in the early postoperative period after robot-assisted radical prostatectomy. J Urol. 2021;205:1671–80.
Jang EB, Hong SH, Kim KS, et al. Catheter-related bladder discomfort: how can we manage it? Int Neurourol J. 2020;24:324–31.
Lu J, Yang X, Zhang J, et al. The efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort: a systematic review and meta-analysis. Medicine (Baltim). 2021;100:e28217.
Myles PS, Myles DB, Galagher W, et al. Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. Br J Anaesth. 2017;118:424–9.
Muñoz-Leyva F, El-Boghdadly K, Chan V. Is the minimal clinically important difference (MCID) in acute pain a good measure of analgesic efficacy in regional anesthesia? Reg Anesth Pain Med. 2020;45:1000–5.